20470 ⎘
Medicinal preparations containing organic active ingredients; Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
LOW-DOSE MIFEPRISTONE FOR THE TREATMENT OF ENDOMETRIOSIS ASSOCIATED PAIN
#2CONTRACEPTIVE COMPOSITIONS WITH REDUCED ADVERSE EFFECTS
#3Methods of Treating Heavy Menstrual Bleeding
#4Dosing Regimens for Elagolix
#5MISOPROSTOL FORMULATION FOR BUCCAL ADMINISTRATION
#6LONG ACTING DRUG DELIVERY DEVICE AND ITS USE IN CONTRACEPTION
#7NEW MODIFIED RELEASE ORAL CONTRACEPTIVE COMPOSITION
#8METHODS OF ORAL CONTRACEPTION BY CONTROLLED RELEASE OF DIENOGEST AND ETHYNYL ESTRADIOL
#9METHOD AND PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING TRICHOMONIASIS AND USES THEREOF
#10PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ALOPECIA INCLUDING AKKERMANSIA
#11TRANSDERMAL PACKAGING MEMBRANES
#12DRUG DELIVERY SYSTEM COMPRISING AN ANTI-INFLAMMATORY AGENT OR A SALT THEREOF FOR THE APPLICATION TO ESOPHAGEAL MUCOUS MEMBRANES
#13APPLICATION OF RAMAN SPECTROSCOPY FOR THE MANUFACTURE OF INHALATION POWDERS
#14Method for improving insulin insensitivity
#15INTRAVAGINAL DEVICES FOR DRUG DELIVERY
#16METHODS AND COMPOSITIONS RELATED TO GLUCOCORTICOID RECEPTOR ANTAGONISTS AND BREAST CANCER
#17FORMULATION OF LONG-ACTING LEVONORGESTREL BUTANOATE INJECTABLE DEPOT SUSPENSION
#18SYNTHETIC PROGESTOGENS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
#19SYNTHETIC PROGESTOGENS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
#20MICROSPHERE COMPOSITION FOR CONTRACEPTIVE MICRONEEDLES AND CONTRACEPTIVE MICRONEEDLES COMPRISING THE SAME
#21Optimizing Mifepristone Absorption
#22ANTI-INFLAMMATORY DRUG-ELUTING COMPOSITIONS AND METHODS
#23COMBINATION THERAPIES AND METHODS OF USE THEREOF FOR TREATING CANCER
#24METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING HERNIAS
#25FORMULATION OF LONG-ACTING LEVONORGESTREL BUTANOATE INJECTABLE DEPOT SUSPENSION
#26FORMULATION OF LONG-ACTING LEVONORGESTREL BUTANOATE INJECTABLE DEPOT SUSPENSION
#27CONTRACEPTIVE METHODS WITH SCHEDULED BLEEDING EFFECTS
#28NOVEL ESTROGEN RECEPTOR MUTATIONS AND USES THEREOF
#29MIFEPRISTONE ORAL FORM FOR ITS USE IN CERVIX RIPENING AND LABOUR INDUCTION
#30HYDROPHILIC FUNCTIONALIZED PARTICLES IN THE DELIVERY OF HYDROPHOBIC DRUGS
#31PHARMACEUTICAL COMPOSITION OF LIFITEGRAST AND LOTEPREDNOL ETABONATE
#32COMBINATION THERAPY INTRAVAGINAL RINGS
#33METHOD AND MEDICAMENT FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS
#34PHARMACEUTICAL COMPOSITIONS OF MIFEPRISTONE
#35COMBINATION THERAPIES AND USES FOR TREATING CANCER
#36GLUCOCORTICOID RECEPTOR BLOCKADE WITH MIFEPRISTONE TO SENSITIZE PANCREATIC CANCER TO IMMUNOTHERAPY
#37Methods of Administering Elagolix
#38Treatment of Hypercoagulopathy in Cushing's Syndrome by Administration of Glucocorticoid Receptor Modulators
#39Synthetic progestogens and pharmaceutical compositions comprising the same
#40Transdermal Systems having low dose estrogen and methods of making and use
#41NEW MODIFIED RELEASE ORAL CONTRACEPTIVE COMPOSITION
#42ETONOGESTREL FORMULATION
#43MODULATION OF CD46 CELL SURFACE MARKER IN BOTH ANDROGEN RECEPTOR-POSITIVE AND NEGATIVE CANCER CELLS
#44METHODS OF ADMINISTERING ELAGOLIX
#45Enhancement of Anti-Angiogenic Cancer Immunotherapy by Abortogenic Agents
#46COMPOSITIONS FOR TREATING INSOMNIA AND USES THEREOF
#47ALTRENOGEST INJECTION AND PREPARATION METHOD AND USE THEREOF
#48PREPARATION FOR ETHINYLESTRADIOL-CYCLODEXTRIN COMPLEX AND USE THEREOF
#49Dosing Regimens for Elagolix
#50USE OF GLUCOCORTICOID RECEPTOR ANTAGONISTS IN COMBINATION WITH GLUCOCORTICOIDS TO TREAT ADRENAL INSUFFICIENCY
#51Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
#52Pharmaceutical compositions of mifepristone
#53METHODS OF TREATING HYPOGONADOTROPIC HYPOGONADISM AND COGNITION IMPAIRMENT FOLLOWING A TRAUMATIC BRAIN INJURY
#54Methods Comprising Continuous Administration of a GLP-1 Receptor Agonist and Co-administration of a Drug
#55NEW MODIFIED RELEASE ORAL CONTRACEPTIVE COMPOSITION
#56DRUG DELIVERY SYSTEM COMPRISING A NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND A PROGESTOGENIC COMPOUND AND METHODS FOR MANUFACTURING
#57METHODS FOR TREATING DISEASES MEDIATED BY GLUTATHIONE PEROXIDASE 4
#58Methods of Administering Elagolix
#59METHODS OF CONTRACEPTION USING NOMEGESTROL ACETATE AND ESTRADIOL
#60THERAPEUTIC AGENTS AND METHODS
#61METHODS OF TREATING SOLID TUMORS DRIVEN BY HER2 ALTERATIONS WITH TUCATINIB IN COMBINATION WITH AN ANTI-HER2 ANTIBODY
#62Synthetic progestogens and pharmaceutical compositions comprising the same
#63STABLE OPHTHALMIC COMPOSITION OF LOTEPREDNOL
#64TREATMENT OF, AND DIFFERENTIAL DIAGNOSIS BETWEEN, ACTH-DEPENDENT CUSHING'S SYNDROME AND ACTH-INDEPENDENT CUSHING'S SYNDROME
#65ORODISPERSIBLE FORMULATIONS
#66HOT MELT EXTRUSION FOR PHARMACEUTICAL VAGINAL FILM PRODUCTS
#67OPHTHALMIC DEVICE
#68MULTIPHASIC CONTRACEPTIVE REGIMEN FOR ORAL COMBINATION DRUG FORMULATION OF PROGESTIN AND ESTROGEN
#69METHODS TO PREVENT HIGH-GRADE SEROUS OVARIAN CANCER AND BREAST CANCER BY ADMINISTERING ANTIPROGESTINS
#70METHOD FOR DIFFERENTIALLY DIAGNOSING ACTH-DEPENDENT CUSHING'S SYNDROME
#71COMBINATION OF CABOTEGRAVIR AND LEVONORGESTREL
#72USES OF GLUCOCORTICOID RECEPTOR (GR) ANTAGONIST AND ANDROGEN RECEPTOR (AR) DEGRADER COMBINATIONS
#73FORMULATIONS INCLUDING 5-[3-(3-HYDROXYPHENOXY)AZETIDIN-1-YL]-5-METHYL-2,2-DIPHENYLHEXANAMIDE
#74Methods of Treating Heavy Menstrual Bleeding
#75COMPOSITIONS FOR TREATING CMT AND RELATED DISORDERS
#76METHODS OF TREATING CASTRATION-RESISTANT PROSTATE CANCER WITH GLUCOCORTICOID RECEPTOR ANTAGONISTS AND ANTI-ANDROGEN RECEPTOR THERAPY AND ANTI-ANDROGEN RECEPTOR THERAPY
#77In-situ Gel Forming Ophthalmic Formulations Containing Difluprednate
#78COMBINATION SOLID ORAL DOSAGE FORMS OF GONADOTROPIN-RELEASING HORMONE ANTAGONISTS
#79ORAL THIN FILM WITH SMOOTH FUSED FILM
#80Combination therapies and methods of use thereof for treating cancer
#81Treatment of hypercoagulopathy in Cushing's syndrome by administration of glucocorticoid receptor modulators
#82METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES
#83Pharmaceutical compositions of mifepristone
#84Orodispersible formulations
#85COMPOSITIONS AND METHODS FOR THE TREATMENT OF ESTROGEN-DEPENDENT DISORDERS
#86Synthetic progestogens and pharmaceutical compositions comprising the same
#87TREATMENT OF PAIN AND/OR PAIN RELATED SYMPTOMS ASSOCIATED WITH DYSMENORRHEA
#88Combination therapy intravaginal rings
#89METHODS OF TREATING LIPEDEMA INCLUDING AKR1C1 AS A THERAPEUTIC TARGET
#90BIODEGRADABLE DRUG DELIVERY FOR HYDROPHOBIC COMPOSITIONS
#91Synthetic progestogens and pharmaceutical compositions comprising the same
#92Synthetic progestogens and pharmaceutical compositions comprising the same
#93ORODISPERSIBLE FORMULATIONS
#94PROCESS FOR THE PREPARATION OF STERILE OPHTHALMIC AQUEOUS FLUTICASONE PROPIONATE FORM A NANOCRYSTALS SUSPENSIONS
#95CYPROTERONE ACETATE COMPOSITIONS AND USES THEREOF
#96COMPOSITIONS AND METHODS FOR THE TREATMENT OF ESTROGEN-DEPENDENT DISORDERS
#97Therapeutic agents and methods
#98Method for Improving Insulin Sensitivity
#99Application of raman spectroscopy for the manufacture of inhalation powders
#100PROBIOTIC THERAPIES FOR SOCIAL DEFICIT AND STRESS RESPONSE
#101Methods of Administering Elagolix
#102Estrogen receptor mutations and uses thereof
#103Optimizing Mifepristone Absorption
#104METHOD FOR PREVENTING HAIR LOSS
#105Bioerodible implant for long-term drug delivery and associated methods of manufacture and use
#106Synthetic progestogens and pharmaceutical compositions comprising the same
#107METHODS, COMPOSITIONS AND DEVICES FOR TREATING NEUROINFLAMMATORY CONDITIONS
#108COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING UVEAL MELANOMA
#109Synthetic progestogens and pharmaceutical compositions comprising the same
#110CONTRACEPTIVE COMPOSITIONS WITH REDUCED ADVERSE EFFECTS
#111METHODS OF DETECTING AND PREDICTING BREAST CANCER
#112Synthetic progestogens and pharmaceutical compositions comprising the same
#113Synthetic progestogens and pharmaceutical compositions comprising the same
#114COMPOUNDS AND METHODS FOR TREATING ABERRANT ADRENOCORTICAL CELL DISORDERS
#115Botanical Extracts and Compounds from Castanea Plants and Methods of Use
#116COMPOSITIONS FOR THE TREATMENT OF CHRONIC VULVAL AND PERINEAL PAIN AND SYMPTOMS AND CONDITIONS ASSOCIATED THEREWITH
#117DOSING REGIMEN OF SEDATIVE
#118PROGESTERONE RECEPTOR ANTAGONIST DOSAGE FORM
#119Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
#120AAntihistamines In Combination With A Range Of Substances For Improved Health
#121Compositions and methods for the treatment of adenomyosis and rectovaginal endometriosis
#122Cyproterone acetate compositions and uses thereof
#123Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof
#124SHORT-ACTING SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
#125Prednisolone and moxifloxacin compositions and methods
#126Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
#127Loteprednol and moxifloxacin compositions and methods
#128Synthetic progestogens and pharmaceutical compositions comprising the same
#129TREATING BREAST CANCER WITH HORMONE RECEPTOR MODULATORS
#130INHIBITORS OF GLUCOCORTICOID RECEPTOR
#131Application of Raman spectroscopy for the manufacture of inhalation powders
#132Methods of treatment for disease from coronavirus exposure
#133Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen
#134Gel Compositions for Transdermal Delivery to Maximize Drug Concentrations in the Stratum Corneum and Serum and Methods of Use Thereof
#135MIFEPRISTONE ORAL FORM FOR ITS USE IN CERVIX RIPENING AND LABOUR INDUCTION
#136Long acting drug delivery device and its use in contraception
#137MICRONEEDLE ARRAY PATCH FOR DRUG DELIVERY AND PRODUCTION METHOD THEREOF
#138Compositions for treating CMT and related disorders
#139METHOD FOR DIFFERENTIALLY DIAGNOSING ACTH-DEPENDENT CUSHING'S SYNDROME
#140Synthesis of New Potent Aromatase Inhibitors Through Biocatalysis of Anti-Cancer Drugs, Atamestane, Drostanolone Enanthate, and Exemestane
#141Dosing Regimens for Elagolix
#142Synthetic progestogens and pharmaceutical compositions comprising the same
#143USE OF ANTAGONISTS TO THE NUCLEAR STEROID RECEPTOR TO INHIBIT CORONAVIRUSES
#144Application of raman spectroscopy for the manufacture of inhalation powders
#145Secnidazole for use in the treatment of bacterial vaginosis
#146METHOD OF TREATING CANCER PREFERABLY CHARACTERIZED BY EXPRESSION OF A FUSION PROTEIN COMPRISING A MEMBER OF THE E-TWENTY-SIX FAMILY BY ADMINISTERING AN AGENT THAT INHIBITS THE SYNTHESIS AND/OR ACTIVITY OF CORTISOL
#147Secnidazole for use in the treatment of sexually transmitted infection
#148Methods comprising continuous administration of exenatide and co-administration of a drug
#149Synthetic progestogens and pharmaceutical compositions comprising the same
#150Biodegradable polymer microparticle containing steroid drug and preparation method therefor
#151ACTIVATION OF MITOCHONDRIAL UNCOUPLING AS A THERAPEUTIC INTERVENTION
#152Methods of treating heavy menstrual bleeding
#153Hot melt extrusion for pharmaceutical vaginal film products
#154ESTROGEN COMBINATION FOR TREATMENT OF MULTIPLE SCLEROSIS
#155METHODS OF DETECTING PROGESTERONE RECEPTOR AND OF DETECTING AN EXPRESSION LEVEL
#156Gonadotropin-releasing hormones for use as adjuvant immunotherapeutics
#157USE OF GLUCOCORTICOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
#158GLUCOCORTICOID RECEPTOR MODULATORS
#159Combination of an ErbB-2/ErbB-3 bispecific antibody with endocrine therapy for breast cancer
#160Optimizing Mifepristone Absorption
#161COMBINATION THERAPIES AND METHODS OF USE THEREOF FOR TREATING CANCER
#162Inhibitors of glucocorticoid receptor
#163Transdermal Delivery
#164Process for the preparation of sterile ophthalmic aqueous fluticasone propionate form a nanocrystals suspensions
#165BIODEGRADABLE DRUG DELIVERY FOR HYDROPHOBIC COMPOSITIONS
#166Treatment of pain and/or pain related symptoms associated with dysmenorrhea
#167VAGINAL RING FOR THE SIMULTANEOUS RELEASE OF TWO ACTIVE INGREDIENTS
#168Use of cortisol in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients
#169Steroidal hormones for the treatment and prevention of wave burst arrhythmia
#170Applications of desogestrel in the preparation of breast cancer ER-negative Ah receptor-positive products
#171Methods of treating castration-resistant prostate cancer with glucocorticoid receptor antagonists and anti-androgen receptor therapy
#172Secnidazole for use in the treatment of trichomoniasis
#173Secnidazole for use in the treatment of trichomoniasis
#174METHODS OF ADMINISTERING ELAGOLIX
#175Optimizing mifepristone levels for Cushing's patients
#176Compositions for treating CMT and related disorders
#177METHODS FOR DIAGNOSING AND ASSESSING TREATMENT FOR CUSHING'S SYNDROME
#178Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
#179Secnidazole for use in the treatment of bacterial vaginosis
#180Treatment of hypercoagulopathy in Cushing's syndrome by administration of glucocorticoid receptor modulators
#181DRUG DELIVERY SYSTEM FOR ULTRA-LOW DOSE ESTROGEN COMBINATIONS AND METHODS AND USES THEREOF
#182PHARMACEUTICAL COMBINATION FOR TREATMENT OF CANCER
#183Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen
#184PERSONALIZED CONTRACEPTIVE FORMULATIONS
#185Methods of administering elagolix
#186COSMETIC AND PHARMACEUTICAL FOAM
#187CYP2J2 antagonists in the treatment of pain
#188METHODS OF TREATING VESTIBULAR SCHWANNOMA
#189Method for differentially diagnosing ACTH-dependent Cushing's syndrome
#190BIODEGRADABLE DRUG DELIVERY FOR HYDROPHOBIC COMPOSITIONS
#191TRANSDERMAL CONTRACEPTIVE HORMONES DELIVERY
#192PHARMACEUTICAL COMPOSITIONS COMPRISING ACTIVE DRUGS, CONTRACEPTIVE KITS COMPRISING ACTIVE DRUGS, AND METHODS OF ADMINISTERING THE SAME
#193Biodegradable contraceptive implants
#194Secnidazole for use in the treatment of bacterial vaginosis
#195Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
#196Secnidazole for use in the treatment of bacterial vaginosis
#197Neuroactive steroids, compositions, and uses thereof
#198Optimizing mifepristone absorption
#199Methods and compositions for modulating hormone levels
#200Use of ACTH in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients
#201Use of cortisol in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients
#202UNIFORM FILMS FOR RAPID DISSOLVE DOSAGE FORM INCORPORATING TASTE-MASKING COMPOSITIONS
#203SELECTIVE PROGESTERONE RECEPTOR MODULATOR (SPRM) REGIMEN
#204Methods for detecting intracranial neoplasms
#205Hard Capsule Shell Compositions for the Oral Contraceptive Formulations
#206Formulation of long-acting levonorgestrel butanoate injectable depot suspension
#207ESTROGEN PRODRUGS AND METHODS OF ADMINISTERING ESTROGEN PRODRUGS
#208TARGETED DELIVERY OF PROGESTINS AND ESTROGENS VIA VAGINAL RING DEVICES FOR FERTILITY CONTROL AND HRT PRODUCTS
#209Body Cavity Foams
#210Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen
#211Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
#212PHARMACEUTICAL COMPOSITIONS COMPRISING ACTIVE DRUGS, CONTRACEPTIVE KITS COMPRISING ACTIVE DRUGS, AND METHODS OF ADMINISTERING THE SAME
#213Progesterone Receptor Modulators for Use in the Therapy of Uterine Fibroids
#214SMALL MOLECULE THERAPEUTIC COMPOUNDS THAT REDUCE THE INCIDENCE OF INTRACEREBRAL HEMORRHAGE AND BRAIN MICROHEMMORHAGES
#215Methods of treating castration-resistant prostate cancer with glucocorticoid receptor antagonists after anticancer therapy
#216Secnidazole for use in the treatment of bacterial vaginosis
#217NOVEL ESTROGEN RECEPTOR MUTATIONS AND USES THEREOF
#218Selective progesterone receptor modulator (SPRM) regimen
#219TREATMENT OF UTERINE FIBROIDS BY INTRAVAGINAL ADMINISTRATION OF A LOW DOSE OF SELECTIVE PROGESTERONE RECEPTOR MODULATOR (SPRM), ANTI-PROGESTIN, OR ANTI-PROGESTATIONAL AGENT
#220DOSAGE REGIMEN FOR THE TREATMENT OF ENDOMETRIOSIS
#221BIODEGRADABLE DRUG DELIVERY FOR HYDROPHOBIC COMPOSITIONS
#222Transdermal packaging membranes
#223METHODS FOR INCREASING EFFICACY OF LIPID FORMULATED siRNA
#224Combination therapy for treating cancer
#225Bioerodible implant for long-term drug delivery and associated methods of manufacture and use
#226Therapeutic and method of use
#227Use of sugar-alcohols in tibolone compositions
#228Combination therapies and methods of use thereof for treating cancer
#229Optimizing mifepristone levels for cushing's patients
#230Longer-acting progestin prodrug contraceptives
#231Combination therapy intravaginal rings
#232Compositions for the treatment of chronic vulval and perineal pain and symptoms and conditions associated therewith
#233Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen
#234CORTICOSTEROID COMPOSITIONS
#235Method for manufacturing a drug delivery device and a drug delivery device manufactured according to the method
#236Selective progesterone receptor modulators (SPRM) and stabilized estrogen level in patient
#237METHODS FOR TREATING POLYCYSTIC KIDNEY DISEASE AND POLYCYSTIC LIVER DISEASE
#238Secnidazole for use in the treatment of bacterial vaginosis
#239Dermal Delivery Compositions And Methods
#240Estrogen receptor mutations and uses thereof
#241Bioerodible contraceptive implant and methods of use thereof
#242Methods of detecting progesterone receptor and of detecting an expression level
#243Methods for diagnosing and assessing treatment for Cushing's syndrome
#244Method for differentially diagnosing ACTH-dependent Cushing's syndrome
#245Intrauterine delivery system for contraception
#246COMPOUNDS AND METHODS FOR TREATING ABERRANT ADRENOCORTICAL CELL DISORDERS
#247Methods and materials for reducing suppression of immune function
#248Compositions for treating CMT and related disorders
#249Systems and methods of managing treatment of a chronic condition by symptom tracking
#250Methods of administering elagolix
#251TRANSDERMAL SYSTEMS CONTAINING MULTILAYER ADHESIVE MATRICES TO MODIFY DRUG DELIVERY
#252Neuroactive steroids, compositions, and uses thereof
#253COSMETIC AND PHARMACEUTICAL FOAM
#254Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen
#255Optimizing mifepristone levels for Cushing's patients
#256Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
#257Applications for levonorgestrel in preparing anti-ovarian cancer products
#258Applications for etonogestrel in preparing anti-prostate cancer products
#259Applications of desogestrel in the preparation of anti-colon cancer/breast cancer ER-negative Ah receptor-positive products
#260USE OF GLUCOCORTICOID RECEPTOR ANTAGONIST AND SOMATOSTATIN ANALOGUES TO TREAT ACTH-SECRETING TUMORS
#261TRANSDERMAL CONTRACEPTIVE HORMONES DELIVERY
#262Transdermal Delivery
#263Long acting drug delivery device and its use in contraception
#264Methods for treating Cushing's syndrome
#265Methods of monitoring estriol therapy
#266Bioerodible implant for long-term drug delivery and associated methods of manufacture and use
#267Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
#268TRANSDERMAL HORMONE DELIVERY
#269Compositions and methods for treating dementia
#270COMBINATION THERAPIES COMPRISING ANTI-ERBB3 AGENTS
#271Small molecule therapeutic compounds that reduce the incidence of intracerebral hemorrhage and brain microhemorrhages
#272METHOD FOR TREATING CANCER BASED ON LEVEL OF GLUCOCORTICOID RECEPTOR
#273Method for differentially diagnosing ACTH-dependent cushing's syndrome
#274Methods of treating castration-resistant prostate cancer with glucocorticoid receptor antagonists
#275DRUG DELIVERY SYSTEM COMPRISING A NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND A PROGESTOGENIC COMPOUND AND METHODS FOR MANUFACTURING
#276Pharmaceutical Compositions Affecting Bioenergetic Processes in a Eukaryotic Biological System and Methods of Treatment
#277INTRAVAGINAL DRUG DELIVERY DEVICE
#278METHOD OF CONTRACEPTION
#279IN SITU GELLING FORM FOR LONG-ACTING DRUG DELIVERY
#280UNIFORM FILMS FOR RAPID DISSOLVE DOSAGE FORM INCORPORATING TASTE-MASKING COMPOSITIONS
#281Method of isolating anti-viral ingredients from , compositions comprising them and their medical use
#282Body Cavity Foams
#283METHODS FOR MANUFACTURING IMPLANTS
#284CYP2J2 ANTAGONISTS IN THE TREATMENT OF PAIN
#285LIPOLYTIC METHODS
#286METHODS AND MATERIALS FOR TREATING ENDOMETRIAL CANCER
#287Intrauterine device, and a method of reducing the rate of diffusion of active ingredients in said intrauterine device
#288Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen
#289PLATINUM-CATALYZED SILICONE DRUG DELIVERY DEVICES AND METHODS OF USE THEREOF
#290Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
#291Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
#292Combination therapies and methods of use thereof for treating cancer
#29317-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases
#294Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
#295Compositions for treating CMT and related disorders
#296Pharmaceutical composition or group of compositions for inhibiting autocrine HCG production in adult human cells
#297Surfactant-stripped micelle compositions with high cargo to surfactant ratio
#298Methods and materials for reducing supression of immune function
#299SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL
#300TRANSDERMAL SYSTEMS CONTAINING MULTILAYER ADHESIVE MATRICES TO MODIFY DRUG DELIVERY